Key result
Capillary electrophoresis correlates strongly with HPLC for amiodarone monitoring with under 10-minute run times.
Why the study?
Amiodarone requires routine serum level monitoring due to toxicity risk, but its hydrophobicity complicates analysis by HPLC and capillary electrophoresis.
A simple capillary electrophoresis method for measuring amiodarone and its active metabolite provides rapid analysis (<10 min) that correlates well with standard HPLC methods.
Answers are grounded in this paper and cite their sources.
May shorten lab turnaround for amiodarone monitoring; leaves open validation before replacing HPLC in practice.
Amiodarone is a broad spectrum antiarrhythmic medication. Toxicity symptoms can occur at high serum levels of this drug; thus the level of this drug requires routine monitoring. Because this drug is very hydrophobic, it is difficult to analyze by both HPLC and capillary electrophoresis (CE). A simple method for measuring amiodarone (A) by CE without sample extraction is described. It is based on separation of the drug in a strong phosphate buffer 170 mmol/L, pH 5.9, with added ethanol, and stacking after acetonitrile deproteinization. The ethanol in the phosphate buffer aids to solubilize the drug, migrate it from the neutral to the cationic molecules region, and to separate it from its metabolite, desethylamiodarone (D). The metabolite D is pharmacologically active; has the similar therapeutic range as the parent drug; similar ultra violet absorption; and at steady state is present at equal ratio. Based on these facts, we choose for routine analysis, conditions where the drug and its metabolite co‐elute. These conditions improved the detection limits, shortened the analysis time (<10 min), and avoided the mathematical addition of the two values to arrive at the therapeutic level. The analysis by CE compared well to that by HPLC, r=0.9. The therapeutic range of the combined values of the amiodarone and the metabolite was estimated to be 1.2–4 mg/L.
No takes yet. Share an insight, caveat, or question.
Shihabi et al. (2005) studied Amiodarone toxicity monitoring. Capillary electrophoresis (CE) vs. HPLC was evaluated on Correlation between CE and HPLC for amiodarone measurement (r=0.9). Capillary electrophoresis compared well to HPLC for measuring amiodarone and its metabolite, with an analysis time of <10 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: